Literature DB >> 27558116

Resolution of Postural Orthostatic Tachycardia Syndrome After CT-Guided, Percutaneous T2 Ethanol Ablation for Hyperhidrosis.

Malcolm Brock1, Tae Hwan Chung2, Sathvika Reddy Gaddam3, Anjaneya Singh Kathait3, Cecily Ober4, Christos Georgiades5.   

Abstract

Postural orthostatic tachycardia syndrome is characterized by orthostatic intolerance. Orthostasis (or other mild physical stress) triggers a cascade of inappropriate tachycardia, lightheadedness, palpitations, and often fainting. The underlying defect is sympathetic dysregulation of the heart, which receives its sympathetic tone from the cervical and upper thoracic sympathetic ganglia. Primary hyperhidrosis is also thought to be the result of sympathetic dysregulation. We present the case of a patient treated with CT-guided, percutaneous T2 EtOH sympatholysis for craniofacial hyperhidrosis. The patient also suffered from postural orthostatic tachycardia syndrome for many years and was unresponsive to treatment. Immediately after sympatholysis, the patient experienced resolution of both craniofacial hyperhidrosis and postural orthostatic tachycardia syndrome.

Entities:  

Keywords:  Autonomic dysregulation; Hyperhidrosis; POTS; Postural orthostatic tachycardia syndrome; Sympatholysis

Mesh:

Substances:

Year:  2016        PMID: 27558116     DOI: 10.1007/s00270-016-1455-6

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  2 in total

1.  Endoscopic thoracic sympathectomy for primary focal hyperhidrosis: impact on psycho-social symptomatology and psychotropic medication use.

Authors:  Dan C Li; Alicia Hulbert; Benjamin Waldbaum; Cecily Ober; Craig M Hooker; Peng Huang; Daniela Molena; Stephen C Yang; Tomoaki Ito; Carisa Perry-Parrish; Malcolm V Brock
Journal:  Eur J Cardiothorac Surg       Date:  2018-11-01       Impact factor: 4.191

2.  Lumbar Sympathetic Nerve Modulation Using Absolute Ethanol for the Treatment of Primary Lower-Extremity Hyperhidrosis: A Dose-Effect Pilot Study.

Authors:  Mingjuan Liu; Huadong Ni; Jiachun Tao; Keyue Xie
Journal:  Med Sci Monit       Date:  2021-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.